Haemonetics 3rd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website
Haemonetics Corporation (NYSE: HAE) announced the availability of its third-quarter fiscal 2021 financial results, concluding on December 26, 2020. A conference call is scheduled for February 2, 2021, at 8:00 a.m. ET, to discuss the results and address investor queries. The earnings release, analytical tables, and details regarding the acquisition of Cardiva Medical, Inc. have been posted on the Investor Relations website. The company's innovative healthcare solutions aim to enhance patient care while reducing healthcare costs.
- Scheduled conference call to discuss fiscal 2021 Q3 results.
- Information on the acquisition of Cardiva Medical indicates growth potential.
- None.
BOSTON, Feb. 2, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal 2021, which ended December 26, 2020, are available on its Investor Relations website.
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on February 2, 2021. The conference call and webcast can be accessed with the following information:
- U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
- Conference ID required for access: 7792833
- A live webcast of the call can be accessed on Haemonetics' Investor Relations website
- Direct link to conference call webcast: https://edge.media-server.com/mmc/p/6nszefg7
In addition, the Company has posted to its Investor Relations website the earnings release, analytical tables and supplemental information as well as a presentation about the Company's pending acquisition of Cardiva Medical, Inc. ("Cardiva") that will be referenced on its conference call and webcast, direct links to which are available below.
Direct link to 3Q FY21 Earnings Release:
https://haemonetics.gcs-web.com/static-files/96ed8312-dab2-41e8-802f-e1f2fdeb21e5
Direct link to 3Q FY21 Analytical Tables and Supplemental Information:
https://haemonetics.gcs-web.com/static-files/c42660a4-daae-4339-9a9d-7c640ad7741b
Direct link to Presentation about Cardiva's acquisition:
https://haemonetics.gcs-web.com/static-files/7b2b766f-d66e-4478-9999-e0dfb0d2a82f
A replay of the conference call and webcast will be available for one year beginning on February 2, 2021 at 11:00 a.m. ET using the conference call webcast link provided in this press release.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our website at http://www.haemonetics.com.
Investor Contact | Media Contact |
Olga Guyette, Director-Investor Relations | Carla Burigatto, VP-Communications |
(781) 356-9763 | (781) 348-7263 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-3rd-quarter-fiscal-year-2021-earnings-release-available-on-investor-relations-website-301219734.html
SOURCE Haemonetics Corporation
FAQ
What are the earnings results for Haemonetics for Q3 fiscal 2021?
When is the conference call for Haemonetics' Q3 fiscal 2021 results?
What key topics will be discussed in Haemonetics' conference call?
Where can I access Haemonetics' Q3 fiscal 2021 earnings release?
